| Literature DB >> 26445534 |
Jean Marie Grosbois1, Alice Gicquello2, Carole Langlois3, Olivier Le Rouzic2, Frédéric Bart4, Benoit Wallaert5, Cécile Chenivesse6.
Abstract
INTRODUCTION: Personalized, global pulmonary rehabilitation (PR) management of patients with COPD is effective, regardless of the place in which this rehabilitation is provided. The objective of this retrospective observational study was to study the long-term outcome of exercise capacity and quality of life during management of patients with COPD treated by home-based PR.Entities:
Keywords: COPD; anxiety; depression; home; pulmonary rehabilitation; quality of life; self-management
Mesh:
Year: 2015 PMID: 26445534 PMCID: PMC4590573 DOI: 10.2147/COPD.S90534
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Flowchart showing participation throughout the study of the patients with COPD managed by home-based PR.
Abbreviation: PR, pulmonary rehabilitation.
Baseline characteristics of the 211 patients who performed the PR program
| Age (years) | 62.3±11.1 |
| Male, n (%) | 143 (67.7) |
| BMI (kg/m2) | 26.8±7.3 |
| FEV1 (% predicted) | 41.5±17.7 |
| FEV1/FVC (%) | 50.4±12.8 |
| Comorbidities, n (%) | |
| 0 | 3 (1.3) |
| 1 | 26 (11.5) |
| 2 | 26 (11.5) |
| ≥3 | 171 (75.7) |
| Treatments, n (%) | |
| Short-acting β2-agonists | 132 (62.5) |
| Long-acting β2-agonists | 95 (45) |
| Long-acting anticholinergic | 158 (74.9) |
| Bronchodilator–corticosteroid combination | 114 (54) |
| Inhaled corticosteroids | 42 (19.9) |
| Oral corticosteroids | 45 (21.3) |
| LTOT | 77 (36.5) |
| LTOT + NIV | 47 (22.3) |
| LTOT + CPAP | 5 (2.4) |
| NIV | 8 (3.8) |
| CPAP | 12 (5.7) |
Note: Data are expressed as mean ± standard deviation.
Abbreviations: PR, pulmonary rehabilitation; BMI, body mass index; FEV1, mean forced expiratory volume in 1 second; FVC, forced vital capacity; LTOT, long-term oxygen therapy; NIV, noninvasive ventilation; CPAP, continuous positive airway pressure.
Post hoc analyses comparing baseline, post-PR, 6 months and 12 months variables
| Baseline | Post-PR | 6 months | 12 months | |
|---|---|---|---|---|
| n | 211 | 195 | 171 | 159 |
| 6MST | 328.9±163 | 394.7±172.6 | 396.5±196.6 | 432.6±182.1 |
| TUG | 10.4±5.9 | 9 2±7.3 | 9.6±5.6 | 9.3±5.4 |
| 10TSTS | 32.3±19.1 | 27.1±14.3 | 28.1±14.3 | 28.6±14 |
| HAD | 17.3±7.3 | 14.5±7.3 | 13.2±7.1 | 13.9±7.5 |
| MRF 28 | 48.5±23.4 | 39.6±23 | 373±23.5 | 39.5±25 |
| VQ11 | 33.4±9.1 | 29.7±9.9 | 27.7±9 | 29.4±10.3 |
| VSRQ | 32.8±15.5 | 40.1±16.4 | 41.6±15.7 | 39.6±16.1 |
Notes: Data are expressed as mean ± standard deviation.
P<0.05,
P<0.001,
P<0.0001, statistical comparison with baseline values;
P<0.05 and
P<0.01, statistical comparison with post-PR values;
P<0.05, statistical comparison with 6 months values. Data are presented as mean ± standard.
Abbreviations: PR, pulmonary rehabilitation; 6MST, 6-minute stepper test (number of steps); TUG, Timed Up and Go; 10TSTS, ten times sit-to-stand test; HAD, Hospital Anxiety and Depression questionnaire; MRF 28, Maugeri Respiratory Failure 28; VSRQ, Visual Simplified Respiratory Questionnaire.